Tocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum.

Saito, Jumpei; Yakuwa, Naho; Kaneko, Kayoko; Takai, Chinatsu; Goto, Mikako; Nakajima, Ken; Yamatani, Akimasa; Murashima, Atsuko

Saito, Jumpei; Yakuwa, Naho; Kaneko, Kayoko; Takai, Chinatsu; Goto, Mikako; Nakajima, Ken; Yamatani, Akimasa; Murashima, Atsuko.

Saito J; Department of Pharmaceuticals.
Yakuwa N; Japan Drug Information Institute in Pregnancy.
Kaneko K; Division of Maternal Medicine, Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.
Takai C; Japan Drug Information Institute in Pregnancy.
Goto M; Japan Drug Information Institute in Pregnancy.
Nakajima K; Japan Drug Information Institute in Pregnancy.
Yamatani A; Department of Pharmaceuticals.
Murashima A; Japan Drug Information Institute in Pregnancy.

Rheumatology (Oxford) ; 58(8): 1505-1507, 2019 08 01.

Article en En | MEDLINE | ID: mdl-30945743

Asunto(s)

Anticuerpos Monoclonales Humanizados/análisis; Sangre Fetal/química; Leche Humana/química; Complicaciones del Embarazo/tratamiento farmacológico; Enfermedad de Still del Adulto/tratamiento farmacológico; Adulto; Anticuerpos Monoclonales Humanizados/efectos adversos; Lactancia Materna; Femenino; Humanos; Lactante; Recién Nacido; Lactancia; Exposición Materna/efectos adversos; Embarazo

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Complicaciones del Embarazo / Enfermedad de Still del Adulto / Sangre Fetal / Anticuerpos Monoclonales Humanizados / Leche Humana Límite: Adult / Female / Humans / Infant / Newborn / Pregnancy Idioma: En Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google